CARDIOVASCULAR ACTIONS OF MELANOCORTINS
黑皮质素的心血管作用
基本信息
- 批准号:7369896
- 负责人:
- 金额:$ 33.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-03-05 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAmericanAnimalsAreaAttenuatedBaroreflexBilateralBradycardiaBrain regionCardiacCardiopulmonaryCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCause of DeathCell NucleusCellsChemicalsChemoreceptorsConditionConsciousCorticotropinCountryDisruptionDorsalEatingElectric StimulationEndocrineExcitatory Amino Acid AntagonistsExcitatory Amino AcidsExperimental DesignsFamilyFeeding behaviorsGABA ReceptorGABA-B ReceptorGenesGlutamate ReceptorGlutamatesGlycineGlycine ReceptorsGoalsHeartHeart RateHyperphagiaHypertensionHypotensionHypothalamic structureInvestigationIpsilateralLaboratoriesLateral Hypothalamic AreaLeadLeftLinkMediatingMelanocortin 3 ReceptorMelanocortin 4 ReceptorMethodsMicroinjectionsMyocardialNeuraxisNeuronsNeurotransmitter ReceptorNucleus solitariusObesityPathway interactionsPeptidesPharmaceutical PreparationsPituitary GlandPressoreceptorsPrincipal InvestigatorPro-OpiomelanocortinProbabilityPublishingRattusReflex actionRegulationReportingReticular FormationRisk FactorsRoleSHU 9119SideSpecificitySpinalStaining methodStainsStressStructureStructure of nucleus infundibularis hypothalamiTachycardiaTechniquesTestingTreatment ProtocolsVagotomyVagus nerve structurealpha-Melanocyte stimulating hormonebasebeta-Endorphinbeta-MSHbiological adaptation to stressdirect applicationexperienceextracellulargamma-Aminobutyric Acidgamma-MSHmelanocortin receptormelanocytenovelnucleus ambiguusprogramsreceptorrelating to nervous systemresearch studyresponsevoltage
项目摘要
Over 61 million Americans have some type of cardiovascular disease that is the leading cause of death in this country. Obesity and stress are two high risk factors for cardiovascular disease, especially hypertension. The melanocortins consist of a family of peptides derived from the common precursor pro-opiomelanocortin. These peptides include alpha-, beta-, and gamma-melanocyte stimulating and adrenocorticotropic hormones. Melanocortins have been implicated in feeding behavior, obesity and stress responses. For example, disruption of melanocortin containing neurons produces over eating and obesity. Mild stress has been reported to elicit over eating that can lead to obesity. In addition, melanocortin levels are elevated in stressful situations. These observations suggest that there may be a link between melanocortins, obesity, stress and cardiovascular disease. A prerequisite for understanding the role of melanocortins in cardiovascular function during obesity and stress is a clear understanding of the role of these peptides in the central cardiovascular regulation in normal conditions. The goal of the present project is to investigate the mechanism of cardiovascular actions of melanocortins in the nucleus tractus solitarius, caudal ventrolateral medullary depressor area, rostral ventrolateral medullary pressor area, the nucleus ambiguus, and the intermediolateral cell column of the thoraco-lumbar cord. These areas of the central nervous system are known to be involved in the regulation of cardiovascular function. Dense neuronal networks containing melanocortins have been identified in these regions. The hypothesis central to this project is that melanocortins excite neurons located in the medullo-spinal regions involved in cardiovascular regulation. The hypothesis is based on our preliminary results and published reports in which electrophysiological studies have shown excitation of neurons in specific regions of the brain. In each of the abovementioned regions, pharmacological and electrophysiological techniques will be used to investigate the mechanism of action of melanocortins. The information generated from this project will eventually be helpful in understanding the mechanisms connecting melanocortins, obesity, stress and cardiovascular disease. Furthermore, this information will help in developing novel and rational regimens of treatment for cardiovascular disease.
超过6100万美国人患有某种类型的心血管疾病,这是该国的主要死亡原因。肥胖和压力是心血管疾病,尤其是高血压的两个高风险因素。黑色素皮质蛋白由源自普通前体促蛋白酶皮质素的肽家族组成。这些肽包括α-,β-和γ-甲状腺细胞刺激和肾上腺皮质激素激素。黑色皮质素与喂养行为,肥胖和压力反应有关。例如,含有神经元的黑色皮质素的破坏会产生饮食和肥胖症。据报道,轻度压力会引起饮食,这可能导致肥胖。另外,在压力的情况下,黑色皮质素水平升高。这些观察结果表明,黑色素皮质,肥胖,压力和心血管疾病之间可能存在联系。了解黑素皮质素在肥胖和压力过程中心血管功能中的作用的先决条件是对这些肽在正常条件下中央心血管调节中的作用的明确理解。本项目的目的是研究黑色素皮质素在核索他叶核中的心血管作用机理,尾腔外侧髓质抑制剂区域,thostral腹侧髓外侧压力区域,Ambiguus核和胸腔宽头胸膜中间型细胞柱。已知中枢神经系统的这些区域与心血管功能的调节有关。在这些区域已经确定了含有黑色皮质素的密集神经元网络。该项目的中心假设是,黑色素皮质激发了位于涉及心血管调节的髓质区域的神经元。该假设是基于我们的初步结果和发表的报告,在该报告中,电生理学研究表明了大脑特定区域的神经元激发。在每个上述区域中,将使用药理学和电生理技术来研究黑色皮质素的作用机理。该项目产生的信息最终将有助于理解连接黑色皮质素,肥胖,压力和心血管疾病的机制。此外,这些信息将有助于开发心血管疾病的新颖和理性治疗方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HREDAY N. SAPRU其他文献
HREDAY N. SAPRU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HREDAY N. SAPRU', 18)}}的其他基金
Central Cardiovascular Regulation and Proangiotensin-12
中枢心血管调节和血管紧张素原 12
- 批准号:
8723590 - 财政年份:2004
- 资助金额:
$ 33.17万 - 项目类别:
Central Cardiovascular Regulation and Proangiotensin-12
中枢心血管调节和血管紧张素原 12
- 批准号:
8457085 - 财政年份:2004
- 资助金额:
$ 33.17万 - 项目类别:
Central Cardiovascular Regulation and Proangiotensin-12
中枢心血管调节和血管紧张素原 12
- 批准号:
8259433 - 财政年份:2004
- 资助金额:
$ 33.17万 - 项目类别:
Central Cardiovascular Regulation and Proangiotensin-12
中枢心血管调节和血管紧张素原 12
- 批准号:
7991442 - 财政年份:2004
- 资助金额:
$ 33.17万 - 项目类别:
相似国自然基金
内源激动剂ArA靶向TMEM175蛋白缓解帕金森病症的分子机制研究
- 批准号:32300565
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Adrb2激动剂在改善呼吸机相关性膈肌功能障碍中的作用与机制研究
- 批准号:82372196
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于OSMAC-GNPS分析策略的蚂蚱内生真菌Aspergillus sp.中新颖泛PPAR激动剂的发现及治疗NASH研究
- 批准号:82304340
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
探究FSP1激动剂在治疗肾缺血再灌注损伤中的分子机理与应用
- 批准号:82304600
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Integrating Tailored Postoperative Opioid Tapering and Pain Management Support for Patients on Long-Term Opioid Use Presenting for Spine Surgery (MIRHIQL)
为脊柱手术中长期使用阿片类药物的患者整合定制的术后阿片类药物逐渐减量和疼痛管理支持 (MIRHIQL)
- 批准号:
10722943 - 财政年份:2023
- 资助金额:
$ 33.17万 - 项目类别:
The lipid hydrolase NAAA as a target for non-addictive analgesic medications
脂质水解酶 NAAA 作为非成瘾性镇痛药物的靶标
- 批准号:
10584428 - 财政年份:2023
- 资助金额:
$ 33.17万 - 项目类别:
Circadian control of neuroinflammation after spinal cord injury
脊髓损伤后神经炎症的昼夜节律控制
- 批准号:
10639178 - 财政年份:2023
- 资助金额:
$ 33.17万 - 项目类别:
PPARdelta receptors and alcohol use phenotypes
PPARδ 受体和饮酒表型
- 批准号:
10682348 - 财政年份:2023
- 资助金额:
$ 33.17万 - 项目类别:
Evaluating the efficacy of a novel NASH therapeutic
评估新型 NASH 疗法的疗效
- 批准号:
10698971 - 财政年份:2023
- 资助金额:
$ 33.17万 - 项目类别: